Health Care [ 8/12 ] | Pharmaceuticals [ 50/74 ]
NASDAQ | Common Stock
MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders.
The company holds exclusiveU. S., Canadian, and Mexican rights for Ketamir-2, a next-generation oral NMDA receptor modulator, that has completed a Phase 1 clinical trial.
It also offers oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia; and SKNY-1, that is in preclinical stage for obesity and nicotine dependence.
The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 3, 26 | -0.03 Increased by +75.09% | - |
| Feb 25, 26 | -0.14 Increased by +18.46% | -0.08 Decreased by -78.37% |
| Dec 3, 25 | -1.18 Decreased by -742.86% | -0.09 Decreased by -1.21 K% |
| Sep 3, 25 | -0.09 Increased by +18.18% | -0.10 Increased by +10.00% |
| May 28, 25 | -0.11 Increased by +8.33% | -0.16 Increased by +31.25% |
| Feb 26, 25 | -0.17 Increased by +52.70% | -0.13 Decreased by -34.62% |
| Nov 27, 24 | -0.14 Increased by +46.15% | -0.11 Decreased by -27.27% |
| Aug 28, 24 | -0.11 Decreased by -10.00% | -0.12 Increased by +8.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 26 | 0.00 Decreased by -100.00% | -1.15 M Increased by +35.52% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 25 | 0.00 Decreased by N/A% | -5.98 M Decreased by -149.34% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -1.14 M Increased by +44.34% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -1.54 M Increased by +9.08% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 11.16 M Increased by +N/A% | -1.78 M Decreased by -3.84% | Decreased by -15.98% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by N/A% | -2.40 M Increased by +58.54% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -2.04 M Increased by +43.03% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.69 M Decreased by -33.58% | Decreased by N/A% Decreased by N/A% |